Skip to content
20-F

Annual Report (Foreign)

IDEX Biometrics ASA

0000950170-23-014791

← back to feed
Filed
Apr 26, 2023 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Diluted FY 2022 · Dec 31, 2022 1.03B sh
Shares Diluted FY 2022 · Dec 31, 2021 918.85M sh
Shares Diluted FY 2022 · Dec 31, 2020 767.07M sh
Shares Outstanding FY 2022 · Dec 31, 2022 1.17B sh
Operating Cash Flow FY 2022 · Dec 31, 2022 −$31.37M
Operating Cash Flow FY 2022 · Dec 31, 2021 −$27.53M
Operating Cash Flow FY 2022 · Dec 31, 2020 −$23.29M
Cash And Equivalents FY 2022 · Dec 31, 2022 $16.12M
Cash And Equivalents FY 2022 · Dec 31, 2021 $33.76M
Cash And Equivalents FY 2022 · Dec 31, 2020 $7.3M
Cash And Equivalents FY 2022 · Dec 31, 2019 $14.13M
Stockholders Equity FY 2022 · Dec 31, 2022 $22.84M
Stockholders Equity FY 2022 · Dec 31, 2021 $37.73M
Stockholders Equity FY 2022 · Dec 31, 2020 $12.51M
Stockholders Equity FY 2022 · Dec 31, 2019 $17.81M
Current Liabilities FY 2022 · Dec 31, 2022 $5.03M
Current Liabilities FY 2022 · Dec 31, 2021 $4.29M
Total Liabilities FY 2022 · Dec 31, 2022 $6.18M
Total Liabilities FY 2022 · Dec 31, 2021 $4.3M
Current Assets FY 2022 · Dec 31, 2022 $23.84M
Current Assets FY 2022 · Dec 31, 2021 $37.35M
Total Assets FY 2022 · Dec 31, 2022 $29.02M
Total Assets FY 2022 · Dec 31, 2021 $42.03M
Rd Expense FY 2022 · Dec 31, 2022 $3.25M
Rd Expense FY 2022 · Dec 31, 2021 $2.68M
Rd Expense FY 2022 · Dec 31, 2020 $1.9M
Net Income FY 2022 · Dec 31, 2022 −$32.66M
Net Income FY 2022 · Dec 31, 2021 −$32.55M
Net Income FY 2022 · Dec 31, 2020 −$26.75M
Operating Income FY 2022 · Dec 31, 2022 −$31.37M
Operating Income FY 2022 · Dec 31, 2021 −$31.35M
Operating Income FY 2022 · Dec 31, 2020 −$26.4M
Revenue FY 2022 · Dec 31, 2022 $4.09M
Revenue FY 2022 · Dec 31, 2021 $2.84M
Revenue FY 2022 · Dec 31, 2020 $1.1M